Use of benzodiazepines and benzodiazepine receptor agonists during pregnancy: Maternal characteristics

Pharmacoepidemiology and Drug Safety

Volumn 16, Issue 9, 2007, Pages 988-994

  Wikner, Birgitta Norstedt ^a   Stiller, Carl Olav ^a   Källén, Bengt ^b   Asker, Charlotte ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF LUND   (Sweden)

Author keywords

Benzodiazepine receptor agonists; Benzodiazepines; Maternal characteristics; Pregnancy

Indexed keywords

ALPRAZOLAM; ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; BENZODIAZEPINE DERIVATIVE; BENZODIAZEPINE RECEPTOR STIMULATING AGENT; CHLORDIAZEPOXIDE; CLOBAZAM; DIAZEPAM; FLUNITRAZEPAM; GESTAGEN; LORAZEPAM; MIDAZOLAM; NEUROLEPTIC AGENT; NITRAZEPAM; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; ORAL CONTRACEPTIVE AGENT; OXAZEPAM; PSYCHOTROPIC AGENT; SEDATIVE AGENT; SEROTONIN UPTAKE INHIBITOR; THYROID HORMONE; TRIAZOLAM; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; ZALEPLON; ZOLPIDEM; ZOPICLONE;

ADULT; ARTICLE; CESAREAN SECTION; CONTROLLED STUDY; EDUCATIONAL STATUS; FEMALE; FEMALE SUBFERTILITY; HUMAN; MAJOR CLINICAL STUDY; MATERNAL AGE; MATERNAL SMOKING; PARITY; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PREGNANT WOMAN; PREMATURE LABOR; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; RISK FACTOR; SPONTANEOUS ABORTION; SWEDEN;

ABORTION, SPONTANEOUS; ADOLESCENT; ADULT; BENZODIAZEPINES; BODY MASS INDEX; CESAREAN SECTION; DELIVERY, OBSTETRIC; EDUCATIONAL STATUS; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; INFANT, NEWBORN; MATERNAL AGE; MIDDLE AGED; MULTIPLE BIRTH OFFSPRING; ODDS RATIO; PREGNANCY; PREGNANCY OUTCOME; RECEPTORS, GABA-A; REGISTRIES; SMOKING; SWEDEN;

EID: 34548719380     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1391     Document Type: Article

References (20)

1. Dolovich LR, Addis A, Vaillancourt JM, et al. Benzodiazepine use in pregnancy and major malformations or oral cleft: meta-analysis of cohort and case-control studies. Br Med J 1998; 317: 839-843.
2. Rementeria JL, Bhatt K. Withdrawal symptoms in neonates from intrauterine exposure to diazepam. J Pediatr 1977; 90: 123-126.
3. Gillberg C. "Floppy infant syndrome" and maternal diazepam. Lancet 1977; 2: 244.
4. McElhatton PR. The effects of benzodiazepine use during pregnancy and lactation. Reprod Toxicol 1994; 8: 461-475.
5. Laegreid L, Olegard R, Walstrom J, et al. Teratogenic effects of benzodiazepine use during pregnancy. J Pediatr 1989; 114: 126-131.
6. Laegreid L, Hagberg G, Lundberg A. Neurodevelopment in late infancy after prenatal exposure to benzodiazepines - a prospective study. Neuropediatrics 1992; 23: 60-67.
7. Mortensen JT, Olsen J, Larsen H, et al. Psychomotor development in children exposed in utero to benzodiazepines, anti-depressants, neuroleptics, and anti-epileptics. Eur J Epidemiol 2003; 18: 769-771.
8. Roehrs T, Roth T. Hypnotics: an update. Curr Neurol Neurosci Rep 2003; 3: 181-184.
9. Diav-Citrin O, Okotore B, Lucarelli K, et al. Pregnancy outcome following first-trimester exposure to zopiclone: a prospective controlled cohort study. Am J Perinatol 1999; 16: 157-160.
10. The National Board of Health and Welfare. The Swedish Medical Birth Register - a summary of content and quality. http://www.sos.se/ FULLTEXT/112/2003-112-3/2003-112-3.pdf
11. Källén B, Otterblad Olausson P. Monitoring of maternal drug use and infant congenital malformations, does loratadine cause hypospadias? Int J Risk Safety Med 2001; 14: 115-119.
12. Källén BA. Methodological issues in the epidemiological study of the teratogenicity of drugs. Congenit Anom 2005; 45: 44-51.
13. Hollier LM, Leveno KJ, Kelly MA, et al. Maternal age and malformations in singleton births. Obstet Gynecol 2000; 96: 701-706.
14. Lindham S. Omphalocele and gastroschisis in Sweden 1965-1976. Acta Paediatr Scand 1981; 70: 55-60.
15. Källén K. Role of maternal smoking and maternal reproductive history in the etiology of hypospadias in the offspring. Teratology 2002; 66: 185-191.
16. Källén K. Maternal smoking and congenital malformations. Fetal Matern Med Rev 2002; 13: 63-86.
17. Dansky LV, Finnell RH. Parental epilepsy, anticonvulsant drugs, and reproductive outcome: epidemiologic and experimental findings spanning three decades; 2: human studies. Reprod Toxicol 91; 5: 301-335.
18. Ghazi HA, Spielberger C, Källén B. Delivery outcome after infertility - a register study. Fertil Steril 1991; 55: 726-732.
19. Ericson A, Källén B, Wiholm B. Delivery outcome after the use of antidepressants in early pregnancy. Eur J Clin Pharmacol 1999; 55: 503-508.
20. Källén B, Rydhstroem H, Åberg A. Asthma during pregnancy - a population based study. Eur J Epidemiol 2000; 16: 167-171.